A randomized, open-labeled, prospective controlled study to assess the efficacy of frontline empirical intravenous piperacillin/tazobactam monotherapy in comparison with ceftazidime plus amikacin for febrile neutropenia in pediatric oncology patients
© 2019 Asian Pacific Organization for Cancer Prevention. Background: Febrile neutropenia (FN) is the most common complication in pediatric oncology patients. Appropriate empirical antibiotics treatment is essential for treatment outcome. Methods: This study was a randomized prospective controlled st...
Saved in:
Main Authors: | Ruchirek Kamonrattana, Lalita Sathitsamitphong, Worawut Choeyprasert, Pimlak Charoenkwan, Rungrote Natesirinilkul, Kanda Fanhchaksai |
---|---|
Format: | Journal |
Published: |
2020
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85072655299&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/67628 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Microbiological equivalence of bacteriostatic and bactericidal activities of the sera from healthy volunteers receiving generic piperacillin/tazobactam (Pipertaz) and original piperacillin/tazobactam (Tazocin).
by: Visanu Thamlikitkul, et al.
Published: (2018) -
Pediatric drug utilization evaluation of cefepime and piperacillin/tazobactam
by: Prasopchoknapaporn P.
Published: (2023) -
Correlation between Amikacin and Ceftazidime pharmacoknetic parameters
by: Sam-ang Kiatjaroensin
Published: (2011) -
Bacteremia in oncologic pediatric patients with febrile neutropenia at Chiang Mai University Hospital between 2007 and 2009
by: Anchalee Wangirapan, et al.
Published: (2019) -
Effectiveness and safety of generic formulation of piperacillin/tazobactam (Astaz-PR) for treatment of infected patients at Siriraj hospital
by: Lantharita Charoenpong, et al.
Published: (2018)